The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Ronald H. Goldfarb

Department of Molecular Biology and Immunology

Institute for Cancer Research

University of North Texas Health Science Center

3500 Camp Bowie Blvd.

USA

[email]@hsc.unt.edu

Name/email consistency: high

[Claim this account]

Affiliations

Department of Molecular Biology and Immunology, Institute for Cancer Research, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., USA. 2002
Department of Molecular Biology, University of North Texas Health Science Center at Fort Worth 76107-2118, USA. 2000
University of Pittsburgh Cancer Institute, USA. 1998 - 1999

References

Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1). Chen, W.S., Kitson, R.P., Goldfarb, R.H. In. Vivo (2002) [Pubmed]
A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin. Goldfarb, R.H., Koelemij, R., Muirhead, K.A., Ohlsson-Wilhelm, B.M., Gray, B.D., Kuppen, P.J., Basse, P.H., al-Atrash, G., Kitson, R.P. In. Vivo (2000) [Pubmed]
Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles. Goldfarb, R.H., Kitson, R.P., Brunson, K.W., Yoshino, K., Hirota, N., Kirii, Y., Kotera, Y., Inoue, Y., Ohashi, M. Anticancer Res. (1999) [Pubmed]
Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide. Goldfarb, R.H., Ohashi, M., Brunson, K.W., Kirii, Y., Kotera, Y., Basse, P.H., Kitson, R.P. Anticancer Res. (1998) [Pubmed]